OBJECTIVE-To describe prepregnancy smoking, pre-natal smoking, and prenatal cessation among women reporting and not reporting depression or anxiety.
subpopulation of women who may have a higher prevalence of smoking and to provide effective tobacco cessation interventions and mental health care.
Approximately 1 of 10 (11.6%) pregnant women smoke in the last 3 months of pregnancy, 1, 2 which is far from the Healthy People 2020 objective of decreasing smoking to 1.4%. 3 Subgroups with high smoking prevalence include young women, those with lower socioeconomic status, substance users, and those with comorbid mental health disorders. [4] [5] [6] Clinical recommendations have included routine tobacco use screening at every prenatal care visit, 7 and the American College of Obstetricians and Gynecologists recommends that clinicians screen all pregnant women for depression and anxiety symptoms. 8 Few population-based studies exist examining the associations between smoking and mental health status around the time of pregnancy. A few studies have reported a significant association between postpartum depression and anxiety and postpartum smoking and relapse. [9] [10] [11] An analysis of a 2001-2002 national sample of women who became pregnant in the past year found independent associations between nicotine dependence and major depression, dysthymia, and panic disorder. 5 However, it is unclear how depression and anxiety are associated with smoking before and during pregnancy. The extent to which pregnant women reporting depression or anxiety smoke can inform tobacco cessation efforts.
We examined prepregnancy smoking, prenatal smoking, and smoking cessation by depression and anxiety status and whether smoking differed by health insurance coverage. Health coverage for smoking cessation and depression treatments may now be covered in Medicaid and insurance plans. [12] [13] [14] [15] Finally, we assessed whether reported depression and anxiety status is independently associated with smoking before and during pregnancy.
MATERIALS AND METHODS
We analyzed cross-sectional data from the 2009-2011 Pregnancy Risk Assessment Monitoring System, which is a state-and population-based surveillance system among women who deliver liveborn neonates in the United States. The Pregnancy Risk Assessment Monitoring System collects data on maternal attitudes and experiences before, during, and shortly after pregnancy. The Pregnancy Risk Assessment Monitoring System methodology has been described elsewhere. 16 Briefly, at each site, a monthly stratified sample of 100-300 new mothers is selected systematically from birth certificates, and these women are contacted by mail. Attempts are made to interview women by phone after nonresponse to repeated mailings. The Pregnancy Risk Assessment Monitoring System survey is completed at 2-6 months after delivery. Data are weighted to represent all women who delivered live births in each site. Of the 40 states and New York City that participated in the Pregnancy Risk Assessment Monitoring System during the study period, our study included nine states (Delaware, Hawaii, Maryland, Michigan, Minnesota, Missouri, Utah, West Virginia, and Wyoming) that queried women about depression and anxiety during the 3 months before pregnancy and achieved an overall weighted response rate of 65% or greater for each state and year in the study period. The Pregnancy Risk Assessment Monitoring System protocol was reviewed and approved by an institutional review board at the Centers for Disease Control and Prevention and each participating state.
We ascertained smoking status in the following way: women who reported that they smoked any amount in the past 2 years were asked how many cigarettes they smoked per day on average during the 3 months before pregnancy and in the last 3 months of pregnancy. Categorical response options were none (0 cigarettes), less than 1, 1-5, 6-10, 11-20, 21-40, or 41 or more. In this study, prepregnancy smoking was defined as smoking any cigarettes in the 3 months before pregnancy. Prenatal smoking was defined as smoking any cigarettes in the last 3 months of pregnancy. Smoking cessation by the last 3 months of pregnancy was defined as smoking "none" in the last 3 months of pregnancy among prepregnancy smokers.
Depression and anxiety status was defined by an affirmative response to either or both of the following questions: "During the 3 months before you got pregnant, did you have anxiety?" and "During the 3 months before you got pregnant, did you have depression?"
Other covariates included in the analysis were maternal age; race and ethnicity; education; marital status; parity; state and neonatal birth year obtained from the linked birth certificate and health insurance coverage before pregnancy; health insurance coverage during prenatal care or at delivery; participation in the Special Supplemental Nutrition Program for Women, Infants, and Children; alcohol binge drinking in 3 months before pregnancy and during the last 3 months of pregnancy; and physical abuse by a partner in the 12 months before pregnancy and during pregnancy were obtained from the Pregnancy Risk Assessment Monitoring System survey.
Data from the nine Pregnancy Risk Assessment Monitoring System states used in the study include 37,419 women. We excluded records with missing data on smoking (n=513), depression or anxiety(n=449), both smoking and depression or anxiety (n=29), and covariates (n=1,795), leaving 34,633 for analysis (92.6% of total sample). The characteristics of the sample were described by depression and anxiety status. Prevalence and 95% confidence intervals (CIs) of prepregnancy smoking, prenatal smoking, and smoking cessation were calculated by depression and anxiety status overall and by selected maternal characteristics, including health insurance coverage. Chi square tests at P<.05 were used to assess differences. Unadjusted and adjusted prevalence ratios of smoking status by depression and anxiety status were calculated per methodology by Bieler et al 17 controlling for all covariates. Analyses were conducted using SAS 9.3 and SUDAAN 11 to account for the complex survey design of the Pregnancy Risk Assessment Monitoring System.
RESULTS
For the total study sample (N=34,633), the majority of women were aged 25-34 years (56.2%), were non-Hispanic white (68.6%), had greater than 12 years of education (61.7%), were married (63.7%), were multiparous (58.1%), had private insurance before pregnancy (62.8%), and were not Special Supplemental Nutrition Program for Women, Infants, and Children participants (56.0%). Overall, 16.9% (95% CI 16.3-17.4, n=5,769) of women reported depression, anxiety, or both during the 3 months before pregnancy (Table 1) ; 4.7% of women reported anxiety only, 4.3% depression only, and 7.9% reported both depression and anxiety. Compared with those without depression or anxiety, women with reported depression or anxiety were more likely to be younger (24 years or younger); non-Hispanic white; have 12 years or less of education; be unmarried; be enrolled in Medicaid insurance before pregnancy; participate in Special Supplemental Nutrition Program for Women, Infants, and Children during pregnancy; be a binge drinker before pregnancy only; and experience physical abuse by a partner before or during pregnancy.
Overall, 26.5% (95% CI 25.9-27.2) of women with a recent live birth reported smoking in the 3 months before pregnancy. Women reporting depression or anxiety had significantly higher prepregnancy smoking prevalence compared with those not reporting either condition (46.7% compared with 22.5%, P<.01) ( Fig. 1 ; Table 2 ). When examined by subgroups, women reporting depression or anxiety had higher prepregnancy smoking prevalence across almost all subgroups with the exception of Native Americans or Alaska Natives and women who were binge drinkers during pregnancy ( Table 2 ). Depressed or anxious women with the highest pre-pregnancy smoking prevalence included those with less than 12 years of education (69.5%); younger than 20 years of age (66.4%); those who experienced physical abuse before and during pregnancy (66.0%), before pregnancy only (65.1%), and during pregnancy only (62.6%); unmarried women (65.2%); and binge drinkers before pregnancy only (61.5%). In adjusted analyses, women reporting depression or anxiety were 1.49 times more likely to smoke pre-pregnancy than those not reporting either condition (Table 3) . Prepregnancy smoking prevalence was significantly higher for women reporting depression or anxiety compared with those not reporting either condition for all insurance categories with the highest smoking prevalence in those reporting depression or anxiety enrolled in Medicaid (67.7%) or who were uninsured (61.5%) (Table 4) . Overall, 13.4% (95% CI 12.8-13.9) of women reported smoking in the last 3 months of pregnancy. Women reporting depression or anxiety had significantly higher prenatal smoking prevalence compared with those not reporting either condition (27.5% compared with 10.5%, P<.01) ( Fig. 1 ; Table 2 ). When examined by subgroups, women reporting depression or anxiety had higher prenatal smoking prevalence across all subgroups than those not reporting either condition (Table 2) . Depressed or anxious women with the highest prenatal smoking prevalence included those with less than 12 years of education (49.4%); those who experienced physical abuse before and during pregnancy (46.5%) and before pregnancy only (46.4%); and unmarried women (41.5%). In adjusted analyses, women reporting depression or anxiety were 1.69 times more likely to smoke in the last 3 months of pregnancy than those not reporting either condition (Table 3) .
Prenatal smoking prevalence was significantly higher for women reporting depression or anxiety for all insurance categories except for those who were uninsured. The highest prenatal smoking prevalence was among women reporting depression or anxiety enrolled in Medicaid (44.8%) or with other insurance (25.8%) ( Table 4) .
Among prepregnancy smokers, 50.2% (95% CI 48.6-51.7) of women reported smoking cessation by the last 3 months of pregnancy. Women reporting depression or anxiety had significantly lower proportions of smoking cessation compared with those not reporting either condition (41.4% compared with 53.8%, P<.01) (Fig. 1) . After adjustment, prepregnancy smokers reporting depression or anxiety were significantly less likely to quit smoking by the last 3 months of pregnancy compared with their counterparts (adjusted prevalence ratio 0.86, 95% CI 0.80-0.92) ( Table 3 ). The point prevalence for smoking cessation was significantly lower for women reporting depression or anxiety enrolled in Medicaid compared with those not reported either condition (32.5% compared with 44.5%) ( Table 4 ).
DISCUSSION
We found that women who reported depression, anxiety, or both had higher smoking prevalence in the 3 months before pregnancy compared with those not reporting either condition; almost half of women reporting depression or anxiety reported smoking. Women reporting depression or anxiety were more likely to smoke during pregnancy and less likely to quit by the last 3 months of pregnancy than those not reporting either condition. Subgroups with the highest smoking prevalence include younger women; those with less education; married women; enrolled in Special Supplemental Nutrition Program for Women, Infants, and Children; and those reporting binge drinking or physical abuse.
Individuals with mental health conditions may perceive tobacco use as an agent to relieve stress and anxiety, and some have reported that traditional cessation interventions do not address their mental health. 18 However, evidence supports that continued smoking can worsen mental health conditions 19 and tobacco cessation improves mental health conditions. In a meta-analysis of 26 longitudinal studies of smokers, tobacco cessation was associated with reduced depression, anxiety, and stress and improved mood and quality of life. 20 Clinical trials of pregnant smokers have also documented improved mental health status and well-being after tobacco cessation. 21-23 An incentive-based cessation trial resulted in increased cessation among pregnant women with diagnosed depression, and the intervention reduced the severity of postpartum depression symptoms. 22 Furthermore, smokers with mental health conditions are just as motivated to quit as those not reporting mental health conditions. 24, 25 Patients and health care providers should be aware that tobacco cessation can contribute to improved mental health and improved pregnancy health.
American College of Obstetricians and Gynecologists guidelines recommend screening for perinatal depression and anxiety at least once during the perinatal period 8 in addition to routine screening for smoking. 7, 26 Given the high comorbidity between mental health status and smoking, preconception, interconception, and prenatal care present opportunities for health care providers to offer evidence-based tobacco cessation interventions and mental health care. Behavioral interventions are the first-line clinical approach for tobacco cessation during pregnancy. 7 There is substantial evidence that behavioral cessation interventions significantly increase smoking cessation by the end of pregnancy and improve birth outcomes. 27 Although cessation itself is associated with improved mental health, 21-23 more research is needed to determine whether interventions that focus on both mental health conditions and smoking may improve both outcomes even further. 21, 28 Ideally, for smokers with mental health conditions, tobacco cessation treatment should be conducted in conjunction with treatment or referral for depression or anxiety. 8 At minimum, all smokers before and during pregnancy should be offered standard-of-care tobacco cessation counseling, and women reporting depression or anxiety may need additional cessation support. Depressed or anxious women who reported physical abuse or binge drinking had very high smoking prevalence, suggesting also a need to screen and provide support for intimate partner violence and alcohol abuse.
We reported that smoking was more common among women reporting depression or anxiety regardless of health insurance coverage. Two thirds of Medicaid-enrolled women who reported depression or anxiety smoked before pregnancy and 45% smoked in the last 3 months of pregnancy. Currently, state Medicaid programs are required to provide comprehensive tobacco cessation treatment to pregnant smokers, and almost all meet this mandate. 29 Increased awareness and broad promotion of tobacco cessation benefits can increase cessation treatment utilization. 30, 31 Additionally, all state programs provide at least some mental health services to Medicaid beneficiaries, 15 and many states offer coverage of depression screening and treatment for pregnant women. 32 Most individual and small group health insurance plans and Medicaid Alternative Benefit Plans are required to cover mental health and substance use disorder services. 15 This analysis has limitations. First, smoking status was self-reported. Although the Pregnancy Risk Assessment Monitoring System ascertains more smokers than other population-based sources relying on self-report, 33 our results may underestimate the true prevalence. 34 Second, depression and anxiety were also self-reported, and the Pregnancy Risk Assessment Monitoring System does not collect data on clinical diagnosis or treatment for these conditions. However, the self-reported estimates of depression (12.2%) and anxiety (12.5%) in the 3 months before pregnancy are consistent with estimates based on selfreported symptoms meeting Diagnostic and Statistical Manual of Mental Disorders, 4th Edition diagnostic criteria of depression (8-11%) and anxiety (12-15%) in pregnant and nonpregnant women. 35, 36 Third, the study is cross-sectional so a causal association cannot be assessed for smoking or depression and anxiety. Finally, results may not be generalizable to women outside of the study states, to those with pregnancy loss, nor outside of the study period.
In conclusion, health care providers have an opportunity to identify and treat reproductiveaged women with tobacco cessation interventions and mental health care. Health care providers should inform patients that tobacco cessation may improve pregnancy outcomes and maternal mental health status. All smokers should be offered cessation counseling, and women reporting depression or anxiety may need additional cessation support. Prevalence of smoking by reported depression or anxiety status (N=34,633 
